Tom Spencer

JANUARY 31, 2025

In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market is expected to grow by around 10% per year from 2024 to 2029. What is life sciences consulting?

Biotechnology 88

Biotechnology Healthcare Pharmaceuticals Consulting 88

Harvard Business

NOVEMBER 29, 2016

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. Historically, the pharmaceutical industry has recruited SAS programmers who have executed well-defined analyses of clinical trials in a standardized, efficient manner.

Data 70

Data Pharmaceuticals Biotechnology Methodologies 70

Harvard Business

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. Profit-driven companies, on the other hand, feel so much pressure to go to market that they often pass on ideas with vast potential. The Valley of Death. Draetta of IACS has found many of the same issues arise in pharmaceutical research.

Government 70

Government Research Journal Biotechnology 70

Tom Spencer

JANUARY 17, 2025

As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. A weakened FDA would not only endanger patient safety but also introduce market uncertainty that biotech companies can ill afford.

Policies 88

Policies Healthcare Biotechnology Industry 88